In summary, our data suggest that the release of the anti-inflammatory adipokine sFRP5 from mature adipocytes in humans is induced by DPP4i which might compensate the sFRP5 deficiency found in COVID-19, but not in bacterial sepsis. Here, SFRP5 is linked to COVID-19.